Studies of endogenous catecholamines in patients with Raynaud's phenomenon secondary to progressive systemic sclerosis (scleroderma).
D002395:Catecholamines / Q000378:metabolism*; D002986:Clinical Trials as Topic; D004837:Epinephrine / Q000097:blood / Q000652:urine; D005260:Female; D005470:Fluorometry; D006801:Humans; D009638:Norepinephrine / Q000097:blood / Q000652:urine; D011928:Raynaud Disease / Q000097:blood / Q000209:etiology / Q000378:metabolism* / Q000652:urine; D012595:Scleroderma, Systemic / Q000150:complications*; D013997:Time Factors
D002395:Catecholamines; D009638:Norepinephrine; D004837:Epinephrine